Table 3.
Generic | Brand | Manufacturer | Form | Onset | Peak | Duration | Availability delivery | Storage |
---|---|---|---|---|---|---|---|---|
NPH | Insulatard | Novo Nordisk | Human | 1–3 h | 4–8 h | 12–16 h | 10 mL vial, 3 mL penfill (5/box) | Refrigerate: 2–8 °C, use within 6 weeks if below 25 °C, and 4 weeks if below 30 °C |
Insugen N | Biocon | |||||||
Humulin N | Eli Lilly | |||||||
Wosulin N | Wockhardt | |||||||
Biosulin L | MJ Biopharm | |||||||
Regular | Actrapid | Novo Nordisk | Human | 30–60 min | 2–4 h | 5–8 h | 10 mL vial, 3 mL penfill (5/box) | Refrigerate: 2–8 °C, use within 6 weeks if below 25 °C, and 4 weeks if below 30 °C |
Insugen R | Biocon | |||||||
Humulin R | Eli Lilly | |||||||
Wosulin R | Wockhardt | |||||||
Biosulin R | MJ Biopharm | |||||||
Lispro | Humalog | Eli Lilly | Analogue | 10–20 min | 30–90 min | 3–5 h | 1 × 5 × 3 mL prefilled pen | |
Aspart | Novo Rapid | Novo Nordisk | Analogue | 10–20 min | 30–90 min | 3–5 h | 1 × 5 × 3 mL prefilled pen | |
Glargine | Lantus | Sanofi | Analogue | 60–90 min | No peak (8–12 h not pronounced) | 20–26 h | 1 × 5 × 3 mL prefilled pen | |
Basolog | Biocon | 1 × 10 mL/1 × 3 mL vials | ||||||
Detemir | Levemir | Novo Nordisk | Analogue | 60–90 min | 20–26 (17.5 h reported) | 1 × 5 × 3 mL prefilled pen | ||
Degludec | Tresiba | Novo Nordisk | Analogue | 30–90 min | No peak | 42 h | 1 × 5 × 3 mL prefilled pen | No refrigeration for 48 days |
Premixed NPH/Regular | Mixtard 30/70 | Novo Nordisk | Human | Dual-acting 30–60 min | Varies maximum effect 2–8 h | 10–16 h | 1 × 10 mL vials and 1 × 5 × 3 mL prefilled pens | Refrigerate: 2–8 °C, use within 6 weeks if below 25 °C, and 4 weeks if below 30 °C |
Insugen 30/70 | Biocon | Human | ||||||
Humalog Mix 25 | Eli Lilly | Human | ||||||
Humalog Mix 50 | Eli Lilly | Human | ||||||
Wosulin 30/70 | Wockhardt | Human | ||||||
Insuman Combo 30 | Sanofi | Human | ||||||
Aspart | NovoMix 30 (70% Protamine/30% Aspart) | Novo Nordisk | Analogue | 5–15 min | Varies; ~ 1 to 4 h | 10–16 h | 1 × 5 × 3 mL prefilled pens | Store below 30 °C |
Adopted from Uganda National Drug Authority (http://nda.or.ug/ug/register/3/Drug-Register.html), Kenya Pharmacy and Poisons Board (http://pharmacyboardkenya.org), Tanzania Food and Drug Authority (https://tfda.go.tz/portal/registered-products), Rwanda Ministry of Health (http://www.moh.gov.rw/fileadmin/user_upload/AUTHORIZED_MEDICINES_AUGUST_2017.pdf), and product leaflets
NPH neutral protamine Hagedorn